NCT01467297View on ClinicalTrials.gov

Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB)

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
COPD Exacerbation
Interventions
DRUG

ceftidoren

ceftidoren 200 mg bid for 5 days

DRUG

levofloxacin

levofloxacin 500 mg once daily for 7 days

Trial Locations (1)

20122

IRCCS Ospedale Maggiore Policlinico via F. Sforza 35, Milan

All Listed Sponsors
lead

University of Milan

OTHER

NCT01467297 - Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) | Biotech Hunter | Biotech Hunter